AESKULISA® for qualitative and quantitative demonstration of IgA, IgG, or IgM antibodies directed against a range of different pathogens supporting a reliable diagnosis of infectious diseases.
Immunoassays are important in routine laboratory services for identification of antibodies in serum or plasma specimens.
AESKULISA® (AESKU Enzyme-Linked Immunosorbent Assay) is a test format particularly suited for the qualitative and quantitative determination of specific IgA, IgG, or IgM antibodies directed against a range of different pathogens.
The following AESKULISA® tests are available order to support the diagnosis of infectious diseases. All assays are calibrated according to our clinically well-characterized, internal Quality Control panels and to all of the latest international standards. It ensures the reliability and reproducibility of our AESKULISA® kits.
Intended Use:
The AESKULISA Clostridium tetani IgG is a qualitative and quantitative immunoassay for the demonstration of human IgG antibodies in serum or plasma directed against tetanus toxoid of Clostridium tetani. The AESKULISA Clostridium tetani IgG test serves for immune status determination.
Recombinant Antigens:
n.a.
Native Antigens:
Tetanus toxoid of Clostridium tetani
Kit Configuration: - Single - G
Cut Off: - 0.08 - 0.12 IU/ml
Range: - 0.03 - 1.00 IU/ml
Standard: - WHO 13/240
Antibodies: - IgG